Pro
00.71.31.92.6USD Million20192020202120222023202420252026
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Healthcare & Pharma
Global Anti-Obesity Drugs Market By Distribution Channel
Charts & Stats
Global Anti-Obesity Drugs Market By TYPE
By TYPE, the market is segmented into Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs), Selective Serotonin 2C Receptor Agonists, and Serotonin-Norepinephrine Reuptake Inhibitors (2019–2035)
Author: Wantstats Research TeamSource: Wantstats Repository
| Label | Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs) | Selective Serotonin 2C Receptor Agonists | Serotonin-Norepinephrine Reuptake Inhibitors |
|---|---|---|---|
| 2019 | 0.0026 USD Million | 0.0005 USD Million | 0.0005 USD Million |
| 2020 | 0.0032 USD Million | 0.0006 USD Million | 0.0005 USD Million |
| 2021 | 0.004 USD Million | 0.0007 USD Million | 0.0007 USD Million |
| 2022 | 0.0055 USD Million | 0.001 USD Million | 0.0009 USD Million |
| 2023 | 0.0081 USD Million | 0.0015 USD Million | 0.0013 USD Million |
| 2024 | 0.0156 USD Million | 0.003 USD Million | 0.0025 USD Million |
| 2025 | 0.0182 USD Million | 0.0035 USD Million | 0.0029 USD Million |
| 2026 | 0.0215 USD Million | 0.0042 USD Million | 0.0034 USD Million |
| 2027 | 0.0254 USD Million | 0.005 USD Million | 0.004 USD Million |
| 2028 | 0.0304 USD Million | 0.006 USD Million | 0.0047 USD Million |
| 2029 | 0.0365 USD Million | 0.0073 USD Million | 0.0056 USD Million |
| 2030 | 0.0442 USD Million | 0.009 USD Million | 0.0066 USD Million |
| 2031 | 0.0539 USD Million | 0.0111 USD Million | 0.008 USD Million |
| 2032 | 0.0662 USD Million | 0.0137 USD Million | 0.0096 USD Million |
| 2033 | 0.0819 USD Million | 0.0172 USD Million | 0.0118 USD Million |
| 2034 | 0.1022 USD Million | 0.0216 USD Million | 0.0145 USD Million |
| 2035 | 0.1286 USD Million | 0.0275 USD Million | 0.0179 USD Million |
Data Source: Wantstats Repository
Growth Outlook
- The Obesity Drugs Market By TYPE portion of the Global Anti market is on a steady long-term growth path. Segment value stands at roughly USD 0 Million in 2026 and is projected to reach USD 0 Million by 2035 — a gain of about 498% over the forecast period, translating to a CAGR in the double digits.
- What the regional split looks like (2026): Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs) leads, holding roughly 74% of segment value — the single largest regional share. Selective Serotonin 2C Receptor Agonists is the second-largest contributor. Serotonin-Norepinephrine Reuptake Inhibitors make up the remainder, in descending order.
- By 2035, Norepinephrine-Dopamine Reuptake Inhibitors (NDRIs) alone is expected to reach USD 0 Million, with Selective Serotonin 2C Receptor Agonists at USD 0 Million.
Market Dynamics
Unlock the Full Data
Get This Chart
Access the complete chart and underlying data to support your research, analysis, and business decisions.
USD49
Buy NowRelated Charts
View AllPro
00.71.42.12.8USD Million20192020202120222023202420252026
Oral
Subcutaneous
Healthcare & Pharma
Global Anti-Obesity Drugs Market By Route Of Administration
Pro
00.71.42.12.8USD Million20192020202120222023202420252026
Centrally Acting Anti-Obesity Drugs
Peripherally Acting Anti-Obesity Drugs
Healthcare & Pharma
Global Anti-Obesity Drugs Market By Mechanism Of Action
Powering the world's best teams.
From next-gen startups to established enterprises.
Contact us
Get in Touch
Let's work together
support@wantstats.comWantstats Research and Media Pvt. Ltd., Office No 104, Pentagon 4, Magarpatta City, Pune - 411028, Maharashtra, India.
See our work in action
Start your data driven journey with us!
What our clients say
Trusted by forward-thinking businesses
for data-driven intelligence
Noah Malgeri
Co-Founder, Mojave Rail Fabrication Limited
This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job.
Michael Robert
Manager, JavolVision
Thanks, I am so happy that we worked together. Maybe we still can work together in the future.
Joseph Aguayo
Sales Operations & Pricing Manager, Intel
Thanks. It's been a pleasure working with you, please use me as reference with any other Intel employees.
Bong Lau
Sales Leader, Bamberg
We bought your "2025 report" in 2020. Everything is fine and very good.
Peter Groot Koerkamp
Account and Business Manager, EFS-Holland BV
Thanks for sending the report it gives us a good global view of the Betaïne market.
Younghwan Choi
Senior Retail Manager, LG Chem
We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.
Mark Irwin
Management Consultant, Level 21
I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.
Rob Kooiker
Group Product Manager HVAC & Fire Protection GMA, Rockwool
I have been reading the first document or the study, the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!
Jason Lee
R&D Director, Seojin
Thanks for your great support. Appreciate it. Well received report. It helps us to understand market well. We're planning other area of survey in the future, let's keep in touch.
Akif Moroglu
Strategy & Business Development Director, Dogan Holding
We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.